{
  "compound": "Nabiximols (Sativex)",
  "condition": "IBD_CROHNS",
  "effect_size": "Medium-large (d = 0.72)",
  "study_type": "RCT",
  "source": "NORML:IBD_RCT_006",
  "participants": "48 Crohn's patients with persistent abdominal pain",
  "year": 2020,
  "notes": "Nabiximols for Abdominal Pain in Crohn's Disease",
  "confidence": "medium",
  "abstract": "Nabiximols: 58% pain reduction vs Placebo: 31% (p<0.05); 67% achieved \u226530% pain reduction"
}